Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 1

Conditions

Stomach Neoplasms 4Gastritis 4Peptic Ulcer 3Dyspepsia 3Lymphoma, B-Cell, Marginal Zone 2Unspecified Adult Solid Tumor, Protocol Specific 1Stomach Ulcer 1Rosacea 1Meibomian Gland Dysfunction 1Lymphoma, Non-Hodgkin 1Lymphoma 1Lung Neoplasms 1Gastritis Dyspepsia Helicobacter Pylori Infection Gastric Cancer Peptic Ulcer 1Exanthema 1Dysbiosis 1Chalazion 1Ameloblastoma 1

Interventions

Irinotecan 16Paclitaxel 14Docetaxel 13Gemcitabine 12Cisplatin 12Capecitabine 8Oxaliplatin 7Temozolomide 6Leucovorin 6Fluorouracil 6Carboplatin 6Topotecan 5Chromatography, High Pressure Liquid 5Polymerase Chain Reaction 4Pharmacogenomic Testing 4Pemetrexed 4Immunohistochemistry 4Filgrastim 4Everolimus 4Etoposide 4Early Intervention, Educational 4Celecoxib 4tipifarnib 3ixabepilone 3bryostatin 1 3Tegafur 3Sorafenib 3Mass Spectrometry 3Magnetic Resonance Spectroscopy 3Lapatinib 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Unspecified Adult Solid Tumor, Protocol Specific × Tetracycline × Clear all
NCT00091247 2017-03-16

Tetracycline in Preventing Skin Rash in Patients Who Are Receiving Drugs Such as Gefitinib and Cetuximab for Cancer

Alliance for Clinical Trials in Oncology

Phase NA Completed
130 enrolled
Other solid neoplasm

Unspecified Adult Solid Tumor, Protocol Specific

Data powered by HemOnc (CC BY 4.0) Colophon âš¡